Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...

Obesity is defined by chronic low-grade inflammation in the body. Fat cells, particularly dysfunctional ones, release ...

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

Women with higher levels of body fat sometimes struggle to conceive and can face greater health risks during pregnancy.

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

The study found body mass index (BMI) patterns that could predict obesity, with findings published in Jama Network Open.

A recent study discovered that obesity increases the risk of breast cancer in women with existing cardiac disease following ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

Fat tissue secretes hormones known as adipokines. Patients with obesity have a larger amount of leptin than a normal ...

Obesity was significantly more prevalent in Black and Hispanic children and adolescents compared with their non-Hispanic White peers and was potentially exacerbated by the COVID-19 pandemic, a study ...